Patrick Wu, MD
Glaucoma Specialist · Houston, TXNPI 1669932794
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,497 of the $10,813 with a category attached, or 60.1%. 13 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 25.1% of the total.
Across 86 payments — averaging $123.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Glaukos Corporation$3K
- AbbVie$2K
- Sight Sciences, Inc.$2K
- NEW World Medical,inc.$708
- Tarsus Pharmaceuticals, Inc.$187
- plus $542 from 7 others
What the payments were for
- Travel & lodging$4,31740%
- Food & beverage$6,49760%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 21 | $2,669 |
| Glaukos Corporation | 9 | $2,589 |
| AbbVie | 28 | $2,355 |
| Sight Sciences, Inc. | 12 | $1,583 |
| NEW World Medical,inc. | 5 | $708 |
| Tarsus Pharmaceuticals, Inc. | 3 | $187 |
| Carl Zeiss Meditec USA, Inc. | 1 | $129 |
| Biotissue Holdings Inc. | 1 | $116 |
| Kedrion Biopharma, Inc. | 1 | $115 |
| Vertex | 1 | $109 |
| Harrow Eye, LLC | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$2,222
- Crystalens Accommodating IOL (AT-52AO)$2,222
- enVista MX60 IOL$2,222
- Trulign IOL$2,222
- Akreos AO IOL$2,222
- iStent Trabecular Micro-Bypass System Model iS3$1,613
- OMNI(R) SURGICAL SYSTEM (US)$1,517
- DURYSTA$886
- XEN GLAUCOMA TREATMENT SYSTEM$787
- Kahook Dual Blade$569
- Clearpath$569
- Ahmed Glaucoma Valve$569
- Streamline$569
- Via360$569
- iDoseTR$516
- iDose$306
- SION SURGICAL INSTRUMENT$283
- TENOGLIDE$181
- iStent Infinite$165
- VERACITY SURGICAL$129
How this compares
$10,633 in reported general payments places this provider in the 80th percentile of 31 glaucoma specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 31 | $1,296 |
| Travoprost | 11 | $588 |
| Latanoprost | 38 | $440 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $358 |
| Brimonidine Tartrate | 35 | $310 |
| MoxifloxacinMoxifloxacin Hcl | 17 | $302 |
| Dorzolamide Hcl | 15 | $175 |
| Timolol Maleate | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Other glaucoma specialist in Houston
- Robert FeldmanHouston$31K
- David LeeHouston$17K
- Elza RachidHouston$4K
- Adam VandenlangenbergHouston$3K
- Ruchi ShahHouston$1K
- Shivani KamatDallas$164K
- Amenze OriaifoAustin$18K
- Nicholas GurneyFt Worth$13K
- Irina VoloskoAustin$11K
- Logan VincentTyler$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.